- Ekso Bionics (EKSO, Financial) integrates AI in exoskeleton devices following NVIDIA Connect Program acceptance.
- AI voice agent developed using NVIDIA Jetson Orin Nano and OpenAI tools for the EksoNR device.
- Extensive dataset of 350,000 patient sessions supports AI-driven exoskeleton advancements.
Ekso Bionics Holdings, Inc. (EKSO), a pioneering company in the field of exoskeleton technology, has announced a successful proof-of-concept for integrating artificial intelligence (AI) into their medical and industrial devices. This breakthrough comes shortly after Ekso Bionics' acceptance into the NVIDIA Connect Program, highlighting the company's commitment to leveraging cutting-edge technology for enhanced device functionality.
As part of this initiative, Ekso Bionics has developed an AI voice agent for its EksoNR device. The integration employs NVIDIA Jetson Orin Nano hardware, NVIDIA JetPack SDK, and OpenAI tools, resulting in an edge AI system capable of operating with or without cloud connectivity. This feature is particularly crucial for medical devices where latency issues are critical.
Ekso Bionics' substantial database, encompassing approximately 350,000 patient sessions and over 15 million individual data points, grows by an impressive 60,000 patient steps daily. This robust dataset not only supports the current AI integration but also positions the company uniquely for future advancements in exoskeleton technology, aiming to broaden the adoption of these devices for personal use beyond clinical settings.
Scott Davis, CEO of Ekso Bionics, emphasized the potential of AI tools to transform human-robot interaction, underscoring the company's efforts to utilize existing data and expertise in driving the broader adoption of exoskeleton technology.
